• 107096+ Medical Conferences
  • 232 Specialties
  • 21591 Organizers
  • 131655 Speakers
  • 151 Countries
  • 4042 Cities
35699+
CME Conference Registrations Sold

SEARCH NEWS
Or

Pharmacy News (4323)

Mon, Oct 1, 2018 - A pharmaceutical executive is defending his company's 400 percent price hike on an antibiotic, according to a report published in Formulary Watch. Read More >
Pharmaceutical Executive Defends 400 Percent Price Hike
Mon, Oct 1, 2018 - Diclofenac initiators have increased cardiovascular risk compared with non-initiators, according to a study published online Sept. 4 in The BMJ. Read More >
Increased Cardiovascular Risk for Diclofenac Initiators
Fri, Sep 28, 2018 - Proton pump inhibitor use is associated with increased risk of hip fracture among dialysis patients, according to a study published online Sept. 27 in the Clinical Journal of the American Society of Nephrology. Read More >
Proton Pump Inhibitor Use Tied to Hip Fracture in Dialysis Patients
Fri, Sep 28, 2018 - Nintedanib plus sildenafil does not provide benefit over nintedanib alone for patients with idiopathic pulmonary fibrosis and diffusion capacity of the lungs for carbon monoxide of 35 percent or less of the predicted value, according to a study published Read More >
Nintedanib Plus Sildenafil No Better Than Nintedanib in IPF
Fri, Sep 28, 2018 - Influenza was deadlier last season than it has been for at least four decades, killing 80,000 Americans. So said the head of the U.S. Centers for Disease Control and Prevention late Tuesday in an interview with the Associated Press. Read More >
80,000 Americans Died From Influenza Over Last Year
Fri, Sep 28, 2018 - In a rare bipartisan move, both the House and Senate have reached a compromise on legislation to address the opioid epidemic. Read More >
Opioid Bill Gets Bipartisan Support
Thu, Sep 27, 2018 - There is a reduction in ovarian cancer risk associated with use of contemporary combined hormonal contraceptives, according to a study published online Sept. 26 in The BMJ. Read More >
Newer Hormonal Contraception May Cut Ovarian Cancer Risk
Thu, Sep 27, 2018 - A single checkpoint inhibitor can be used to successfully treat two simultaneous types of primary cancer in a patient with Lynch syndrome, according to a research letter published online Sept. 25 in the Annals of Internal Medicine. Read More >
Single Agent Treats Two Cancers With Same Genetic Cause